Neuronetics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuronetics, Inc. on February 27, 2023, covering events that occurred on February 21, 2023. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol "STIM".
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on executive compensation arrangements.
Material Changes and Executive Compensation
On February 21, 2023, the Compensation Committee of the Board of Directors approved annual cash incentive compensation awards for two executive officers. Additionally, a recommendation was made for the CEO's award, pending Board approval.
- Stephen Furlong (Executive Vice President, Chief Financial Officer, and Treasurer): Approved award of $276,901.
- W. Andrew Macan (Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary): Approved award of $252,914.
- Keith J. Sullivan (President and Chief Executive Officer): Recommended award of $841,620, subject to Board approval at the March 2, 2023 meeting.
The approved awards are scheduled to be paid on or about March 9, 2023.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding business outlook, guidance, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the final Board approval of the $841,620 cash incentive award for CEO Keith J. Sullivan at the March 2, 2023 meeting.
- Confirm the payment date of the approved awards for the CFO and General Counsel on or about March 9, 2023.
- Note that this filing does not contain financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.